EUCTR2004-001825-69-IT进行中（未招募）不适用
A Multi Center, Open label, Extension study of RA 1 using Extracoproreal photoimmune therapy with Uvadex
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- THERAKOS
- 入组人数
- 68
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Extension study to the multicenter, open-label, randomized, controlled study CRAD001H2304 to evaluate the long-term efficacy and safety of concentration-controlled everolimus in liver transplant recipientsEUCTR2009-017311-15-HUovartis Pharma Services AG470
进行中（未招募）
不适用
Extension study to the multicenter, open-label, randomized, controlled study CRAD001H2304 to evaluate the long-term efficacy and safety of concentration-controlled everolimus in liver transplant recipientsprophylaxis of liver allograft rejection in liver transplant recipientsMedDRA version: 14.1Level: LLTClassification code 10066543Term: Acute allograft rejectionSystem Organ Class: 10021428 - Immune system disordersEUCTR2009-017311-15-CZovartis Pharma Services AG470
进行中（未招募）
不适用
Extension study to the multicenter, open-label, randomized, controlled study CRAD001H2304 to evaluate the long-term efficacy and safety of concentration-controlled everolimus in liver transplant recipientsprophylaxis of liver allograft rejection in liver transplant recipientsMedDRA version: 12.1Level: LLTClassification code 10066543Term: Acute allograft rejectionEUCTR2009-017311-15-NLovartis Pharma Services AG470
已完成
3 期
Extension study to the multicenter, open-label, randomized, controlled study CRAD001H2304 to evaluate the long-term efficacy and safety of concentrationcontrolled everolimus in liver transplant recipients.NL-OMON34870ovartis28
进行中（未招募）
不适用
Extension study to the multicenter, open-label, randomized, controlled study CRAD001H2304 to evaluate the long-term efficacy and safety of concentration-controlled everolimus in liver transplant recipientsprophylaxis of liver allograft rejection in liver transplant recipientsMedDRA version: 12.1Level: LLTClassification code 10066543Term: Acute allograft rejectionEUCTR2009-017311-15-IEovartis Pharma Services AG470